RCG Macon (Noxubee County) is a medicare approved dialysis facility center in Macon, Mississippi and it has 16 dialysis stations. It is located in Noxubee county at 703 North Washington Street, Macon, MS, 39341. You can reach out to the office of RCG Macon (Noxubee County) at (662) 726-9866. This dialysis clinic is managed and/or owned by Fresenius Medical Care. RCG Macon (Noxubee County) has the following ownership type - Profit. It was first certified by medicare in February, 2000. The medicare id for this facility is 252560 and it accepts patients under medicare ESRD program.
| Name | RCG Macon (Noxubee County) |
|---|---|
| Location | 703 North Washington Street, Macon, Mississippi |
| No. of Dialysis Stations | 16 |
| Medicare ID | 252560 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 703 North Washington Street, Macon, Mississippi, 39341 | |
| (662) 726-9866 | |
News Archive
The discovery opens the possibility that blood vessel growth (angiogenesis) one day may be induced, or stymied, for therapeutic use against heart disease, cancer, and other illnesses, according to Dean Y. Li, M.D., Ph.D., associate professor of internal medicine in the U of U School of Medicine's Division of Cardiology.
Scientists at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health have discovered abnormal levels of specific gut bacteria related to chronic fatigue syndrome/myalgic encephalomyelitis, or ME/CFS, in patients with and without concurrent irritable bowel syndrome, or IBS.
Up to one million people - mainly pregnant woman and young children - are killed each year by the Plasmodium falciparum parasite, which causes the most devastating form of human malaria.
Cellectis stem cells, a Business Unit of Cellectis Group, a premier provider of stem cell derived products and technologies, today announces the launch of a human iPS derived hepatocyte product, hiPS-HEP.
The Global Health Technologies Coalition's "Breakthroughs" blog reports on the Consortium of Universities for Global Health annual conference held last week, highlighting "a panel hosted by the GHTC, which focused on current fiscal and policy realities in the United States that will impact global health research and development in the coming year and beyond."
› Verified 4 days ago
| NPI Number | 1356453187 |
| Organization Name | Rcg Macon |
| Doing Business As | Rcg Mississippi, Inc. |
| Address | 703 N Washington St Macon, Mississippi, 39341 |
| Phone Number | (662) 726-9866 |
News Archive
The discovery opens the possibility that blood vessel growth (angiogenesis) one day may be induced, or stymied, for therapeutic use against heart disease, cancer, and other illnesses, according to Dean Y. Li, M.D., Ph.D., associate professor of internal medicine in the U of U School of Medicine's Division of Cardiology.
Scientists at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health have discovered abnormal levels of specific gut bacteria related to chronic fatigue syndrome/myalgic encephalomyelitis, or ME/CFS, in patients with and without concurrent irritable bowel syndrome, or IBS.
Up to one million people - mainly pregnant woman and young children - are killed each year by the Plasmodium falciparum parasite, which causes the most devastating form of human malaria.
Cellectis stem cells, a Business Unit of Cellectis Group, a premier provider of stem cell derived products and technologies, today announces the launch of a human iPS derived hepatocyte product, hiPS-HEP.
The Global Health Technologies Coalition's "Breakthroughs" blog reports on the Consortium of Universities for Global Health annual conference held last week, highlighting "a panel hosted by the GHTC, which focused on current fiscal and policy realities in the United States that will impact global health research and development in the coming year and beyond."
› Verified 4 days ago
| Dialysis patients with Hemoglobin data | 45 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 7 |
News Archive
The discovery opens the possibility that blood vessel growth (angiogenesis) one day may be induced, or stymied, for therapeutic use against heart disease, cancer, and other illnesses, according to Dean Y. Li, M.D., Ph.D., associate professor of internal medicine in the U of U School of Medicine's Division of Cardiology.
Scientists at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health have discovered abnormal levels of specific gut bacteria related to chronic fatigue syndrome/myalgic encephalomyelitis, or ME/CFS, in patients with and without concurrent irritable bowel syndrome, or IBS.
Up to one million people - mainly pregnant woman and young children - are killed each year by the Plasmodium falciparum parasite, which causes the most devastating form of human malaria.
Cellectis stem cells, a Business Unit of Cellectis Group, a premier provider of stem cell derived products and technologies, today announces the launch of a human iPS derived hepatocyte product, hiPS-HEP.
The Global Health Technologies Coalition's "Breakthroughs" blog reports on the Consortium of Universities for Global Health annual conference held last week, highlighting "a panel hosted by the GHTC, which focused on current fiscal and policy realities in the United States that will impact global health research and development in the coming year and beyond."
› Verified 4 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 58 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 579 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
The discovery opens the possibility that blood vessel growth (angiogenesis) one day may be induced, or stymied, for therapeutic use against heart disease, cancer, and other illnesses, according to Dean Y. Li, M.D., Ph.D., associate professor of internal medicine in the U of U School of Medicine's Division of Cardiology.
Scientists at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health have discovered abnormal levels of specific gut bacteria related to chronic fatigue syndrome/myalgic encephalomyelitis, or ME/CFS, in patients with and without concurrent irritable bowel syndrome, or IBS.
Up to one million people - mainly pregnant woman and young children - are killed each year by the Plasmodium falciparum parasite, which causes the most devastating form of human malaria.
Cellectis stem cells, a Business Unit of Cellectis Group, a premier provider of stem cell derived products and technologies, today announces the launch of a human iPS derived hepatocyte product, hiPS-HEP.
The Global Health Technologies Coalition's "Breakthroughs" blog reports on the Consortium of Universities for Global Health annual conference held last week, highlighting "a panel hosted by the GHTC, which focused on current fiscal and policy realities in the United States that will impact global health research and development in the coming year and beyond."
› Verified 4 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at RCG Macon (Noxubee County) with elevated calcium levels.
| Patients with hypercalcemia | 61 |
| Hypercalcemia patient months | 593 |
| Patients with Serumphosphor | 63 |
| Patients with Serumphosphor less than 3.5 mg/dL | 12 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 28 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 32 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 17 |
| Patients with Serumphosphor greater than 7 mg/dL | 12 |
News Archive
The discovery opens the possibility that blood vessel growth (angiogenesis) one day may be induced, or stymied, for therapeutic use against heart disease, cancer, and other illnesses, according to Dean Y. Li, M.D., Ph.D., associate professor of internal medicine in the U of U School of Medicine's Division of Cardiology.
Scientists at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health have discovered abnormal levels of specific gut bacteria related to chronic fatigue syndrome/myalgic encephalomyelitis, or ME/CFS, in patients with and without concurrent irritable bowel syndrome, or IBS.
Up to one million people - mainly pregnant woman and young children - are killed each year by the Plasmodium falciparum parasite, which causes the most devastating form of human malaria.
Cellectis stem cells, a Business Unit of Cellectis Group, a premier provider of stem cell derived products and technologies, today announces the launch of a human iPS derived hepatocyte product, hiPS-HEP.
The Global Health Technologies Coalition's "Breakthroughs" blog reports on the Consortium of Universities for Global Health annual conference held last week, highlighting "a panel hosted by the GHTC, which focused on current fiscal and policy realities in the United States that will impact global health research and development in the coming year and beyond."
› Verified 4 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 68 |
| Patient months included in arterial venous fistula and catheter summaries | 615 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 68 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 7 |
News Archive
The discovery opens the possibility that blood vessel growth (angiogenesis) one day may be induced, or stymied, for therapeutic use against heart disease, cancer, and other illnesses, according to Dean Y. Li, M.D., Ph.D., associate professor of internal medicine in the U of U School of Medicine's Division of Cardiology.
Scientists at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health have discovered abnormal levels of specific gut bacteria related to chronic fatigue syndrome/myalgic encephalomyelitis, or ME/CFS, in patients with and without concurrent irritable bowel syndrome, or IBS.
Up to one million people - mainly pregnant woman and young children - are killed each year by the Plasmodium falciparum parasite, which causes the most devastating form of human malaria.
Cellectis stem cells, a Business Unit of Cellectis Group, a premier provider of stem cell derived products and technologies, today announces the launch of a human iPS derived hepatocyte product, hiPS-HEP.
The Global Health Technologies Coalition's "Breakthroughs" blog reports on the Consortium of Universities for Global Health annual conference held last week, highlighting "a panel hosted by the GHTC, which focused on current fiscal and policy realities in the United States that will impact global health research and development in the coming year and beyond."
› Verified 4 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 65 |
| Hospitalization Rate in facility | 36.9 (Better than Expected) |
| Hospitalization Rate: Upper Confidence Limit | 118.4 |
| Hospitalization Rate: Lower Confidence Limit | 12.3 |
News Archive
The discovery opens the possibility that blood vessel growth (angiogenesis) one day may be induced, or stymied, for therapeutic use against heart disease, cancer, and other illnesses, according to Dean Y. Li, M.D., Ph.D., associate professor of internal medicine in the U of U School of Medicine's Division of Cardiology.
Scientists at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health have discovered abnormal levels of specific gut bacteria related to chronic fatigue syndrome/myalgic encephalomyelitis, or ME/CFS, in patients with and without concurrent irritable bowel syndrome, or IBS.
Up to one million people - mainly pregnant woman and young children - are killed each year by the Plasmodium falciparum parasite, which causes the most devastating form of human malaria.
Cellectis stem cells, a Business Unit of Cellectis Group, a premier provider of stem cell derived products and technologies, today announces the launch of a human iPS derived hepatocyte product, hiPS-HEP.
The Global Health Technologies Coalition's "Breakthroughs" blog reports on the Consortium of Universities for Global Health annual conference held last week, highlighting "a panel hosted by the GHTC, which focused on current fiscal and policy realities in the United States that will impact global health research and development in the coming year and beyond."
› Verified 4 days ago
The rate of readmission show you whether patients who were being treated regularly at RCG Macon (Noxubee County) were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 20.2 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 57.4 |
| Readmission Rate: Lower Confidence Limit | 3 |
News Archive
The discovery opens the possibility that blood vessel growth (angiogenesis) one day may be induced, or stymied, for therapeutic use against heart disease, cancer, and other illnesses, according to Dean Y. Li, M.D., Ph.D., associate professor of internal medicine in the U of U School of Medicine's Division of Cardiology.
Scientists at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health have discovered abnormal levels of specific gut bacteria related to chronic fatigue syndrome/myalgic encephalomyelitis, or ME/CFS, in patients with and without concurrent irritable bowel syndrome, or IBS.
Up to one million people - mainly pregnant woman and young children - are killed each year by the Plasmodium falciparum parasite, which causes the most devastating form of human malaria.
Cellectis stem cells, a Business Unit of Cellectis Group, a premier provider of stem cell derived products and technologies, today announces the launch of a human iPS derived hepatocyte product, hiPS-HEP.
The Global Health Technologies Coalition's "Breakthroughs" blog reports on the Consortium of Universities for Global Health annual conference held last week, highlighting "a panel hosted by the GHTC, which focused on current fiscal and policy realities in the United States that will impact global health research and development in the coming year and beyond."
› Verified 4 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at RCG Macon (Noxubee County) get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .29 (As Expected) |
| SIR: Upper Confidence Limit | 1.43 |
| SIR: Lower Confidence Limit | .01 |
News Archive
The discovery opens the possibility that blood vessel growth (angiogenesis) one day may be induced, or stymied, for therapeutic use against heart disease, cancer, and other illnesses, according to Dean Y. Li, M.D., Ph.D., associate professor of internal medicine in the U of U School of Medicine's Division of Cardiology.
Scientists at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health have discovered abnormal levels of specific gut bacteria related to chronic fatigue syndrome/myalgic encephalomyelitis, or ME/CFS, in patients with and without concurrent irritable bowel syndrome, or IBS.
Up to one million people - mainly pregnant woman and young children - are killed each year by the Plasmodium falciparum parasite, which causes the most devastating form of human malaria.
Cellectis stem cells, a Business Unit of Cellectis Group, a premier provider of stem cell derived products and technologies, today announces the launch of a human iPS derived hepatocyte product, hiPS-HEP.
The Global Health Technologies Coalition's "Breakthroughs" blog reports on the Consortium of Universities for Global Health annual conference held last week, highlighting "a panel hosted by the GHTC, which focused on current fiscal and policy realities in the United States that will impact global health research and development in the coming year and beyond."
› Verified 4 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether RCG Macon (Noxubee County)'s rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 59 |
| Transfusion Rate in facility | 22.8 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 69.7 |
| Transfusion Rate: Lower Confidence Limit | 8.6 |
News Archive
The discovery opens the possibility that blood vessel growth (angiogenesis) one day may be induced, or stymied, for therapeutic use against heart disease, cancer, and other illnesses, according to Dean Y. Li, M.D., Ph.D., associate professor of internal medicine in the U of U School of Medicine's Division of Cardiology.
Scientists at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health have discovered abnormal levels of specific gut bacteria related to chronic fatigue syndrome/myalgic encephalomyelitis, or ME/CFS, in patients with and without concurrent irritable bowel syndrome, or IBS.
Up to one million people - mainly pregnant woman and young children - are killed each year by the Plasmodium falciparum parasite, which causes the most devastating form of human malaria.
Cellectis stem cells, a Business Unit of Cellectis Group, a premier provider of stem cell derived products and technologies, today announces the launch of a human iPS derived hepatocyte product, hiPS-HEP.
The Global Health Technologies Coalition's "Breakthroughs" blog reports on the Consortium of Universities for Global Health annual conference held last week, highlighting "a panel hosted by the GHTC, which focused on current fiscal and policy realities in the United States that will impact global health research and development in the coming year and beyond."
› Verified 4 days ago
The rate of mortality show you whether patients who were being treated regularly at RCG Macon (Noxubee County) lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 295 |
| Mortality Rate in facility | 10 (Better than Expected) |
| Mortality Rate: Upper Confidence Limit | 15.3 |
| Mortality Rate: Lower Confidence Limit | 6.2 |
News Archive
The discovery opens the possibility that blood vessel growth (angiogenesis) one day may be induced, or stymied, for therapeutic use against heart disease, cancer, and other illnesses, according to Dean Y. Li, M.D., Ph.D., associate professor of internal medicine in the U of U School of Medicine's Division of Cardiology.
Scientists at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health have discovered abnormal levels of specific gut bacteria related to chronic fatigue syndrome/myalgic encephalomyelitis, or ME/CFS, in patients with and without concurrent irritable bowel syndrome, or IBS.
Up to one million people - mainly pregnant woman and young children - are killed each year by the Plasmodium falciparum parasite, which causes the most devastating form of human malaria.
Cellectis stem cells, a Business Unit of Cellectis Group, a premier provider of stem cell derived products and technologies, today announces the launch of a human iPS derived hepatocyte product, hiPS-HEP.
The Global Health Technologies Coalition's "Breakthroughs" blog reports on the Consortium of Universities for Global Health annual conference held last week, highlighting "a panel hosted by the GHTC, which focused on current fiscal and policy realities in the United States that will impact global health research and development in the coming year and beyond."
› Verified 4 days ago
RCG Macon (Noxubee County) Location: 703 North Washington Street, Macon, Mississippi, 39341 Phone: (662) 726-9866 |
News Archive
The discovery opens the possibility that blood vessel growth (angiogenesis) one day may be induced, or stymied, for therapeutic use against heart disease, cancer, and other illnesses, according to Dean Y. Li, M.D., Ph.D., associate professor of internal medicine in the U of U School of Medicine's Division of Cardiology.
Scientists at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health have discovered abnormal levels of specific gut bacteria related to chronic fatigue syndrome/myalgic encephalomyelitis, or ME/CFS, in patients with and without concurrent irritable bowel syndrome, or IBS.
Up to one million people - mainly pregnant woman and young children - are killed each year by the Plasmodium falciparum parasite, which causes the most devastating form of human malaria.
Cellectis stem cells, a Business Unit of Cellectis Group, a premier provider of stem cell derived products and technologies, today announces the launch of a human iPS derived hepatocyte product, hiPS-HEP.
The Global Health Technologies Coalition's "Breakthroughs" blog reports on the Consortium of Universities for Global Health annual conference held last week, highlighting "a panel hosted by the GHTC, which focused on current fiscal and policy realities in the United States that will impact global health research and development in the coming year and beyond."
› Verified 4 days ago